Progress Report: Cory Abate-Shen, Ph.D


Investigator: Cory Abate-Shen, PhD–Professor of Urology and Pathology, Director of Research, Department of Urology, Associate Director, Herbert Irving Comprehensive Cancer Center, Columbia University

Identification of Oncogenic Pathways Conserved from Mouse to Man

Dr. Abate-Shen’s research goals are to identify new molecules that drive prostate cancer progression. Her approach to this problem is novel. Dr. Abate-Shen is using state-of-the-art systems biology to dissect out master control genes of prostate cancer by comparing data collected from both human and mouse studies. Systems biology is defined as the study of multiple cellular components simultaneously using rigorous data integration with mathematical models to understand overall cellular function.

Since there is a high degree of genetic conservation between human and mouse the hypothesis is that molecules that are identified as abundant in prostate cancer of both species are likely critical drivers of the disease. Dr. Abate-Shen and her team have made significant progress in developing the platform required to establish this global systems biology program. The hope is that this program will identify new therapeutic targets for prostate cancer treatments.

Terms to know from this article:

Progression

Increase in the size of a tumor or spread of cancer in the body.